• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

Curaleaf Reports Q1 2026 Financial Results

STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began ...

LeafLink Releases 2026 Wholesale Cannabis Pricing Guide

NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal ...

LEEF Brands Reports Q4 and FY 2025 Financial Results

VANCOUVER – LEEF Brands Inc. released its fourth-quarter and full-year 2025 financial results, showing the first clear effects of its shift to in-house cultivation at the Salisbury Canyon Ranch in California. In an industry still ...

Curaleaf Reports Q1 2026 Financial Results

STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began ...

LeafLink Releases 2026 Wholesale Cannabis Pricing Guide

NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal ...

Algernon Pharmaceuticals Advances Research Program

LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...

Glass House Brands Report Revenue and Profits

LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...

ICER Raises Concerns Over MDMA-Assisted Psychotherapy for PTSD

LOS ANGELES- The Institute for Clinical and Economic Review (ICER) has recently highlighted significant concerns regarding the clinical evidence behind MDMA-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD), according to a draft evidence report. This ...

Psilera Strengthens Board with Neuroscience

TAMPA –Psilera, a biotechnology company specializing in novel treatments for complex neurological disorders, has announced the addition of Dr. Magali Haas, M.D., Ph.D., to its Board of Directors. Dr. Haas, with an illustrious career spanning ...

Subscribe To Our Newsletter

Go to Top